Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 10 | 2020 | 708 | 1.620 |
Why?
|
| Hemoglobin, Sickle | 4 | 2010 | 25 | 0.820 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 42 | 0.750 |
Why?
|
| Aspirin | 3 | 2017 | 455 | 0.650 |
Why?
|
| Preoperative Care | 4 | 2017 | 1529 | 0.620 |
Why?
|
| Solutions | 6 | 2010 | 105 | 0.600 |
Why?
|
| Proteins | 4 | 2010 | 1953 | 0.570 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2016 | 110 | 0.560 |
Why?
|
| Syndrome | 2 | 2022 | 1351 | 0.560 |
Why?
|
| Coronary Vessels | 2 | 2020 | 666 | 0.550 |
Why?
|
| Postoperative Complications | 5 | 2017 | 5566 | 0.530 |
Why?
|
| Coronary Artery Disease | 3 | 2020 | 1014 | 0.490 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2013 | 423 | 0.470 |
Why?
|
| Leukemia | 2 | 2022 | 1633 | 0.470 |
Why?
|
| Heme | 2 | 2010 | 79 | 0.440 |
Why?
|
| Models, Genetic | 1 | 2016 | 1111 | 0.420 |
Why?
|
| Cognition | 1 | 2018 | 973 | 0.420 |
Why?
|
| Heart Atria | 2 | 2012 | 352 | 0.420 |
Why?
|
| Sodium | 1 | 2013 | 352 | 0.420 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 1083 | 0.420 |
Why?
|
| Protein Conformation | 4 | 2010 | 1258 | 0.410 |
Why?
|
| Renal Insufficiency | 3 | 2010 | 322 | 0.410 |
Why?
|
| Exercise | 2 | 2022 | 1186 | 0.410 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 53 | 0.410 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 389 | 0.360 |
Why?
|
| Models, Chemical | 3 | 2009 | 186 | 0.350 |
Why?
|
| Crystallization | 4 | 2023 | 135 | 0.350 |
Why?
|
| Viscoelastic Substances | 1 | 2009 | 1 | 0.340 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 1237 | 0.340 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 155 | 0.330 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 222 | 0.320 |
Why?
|
| Genetic Variation | 1 | 2016 | 2090 | 0.320 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 175 | 0.310 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 158 | 0.300 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 303 | 0.300 |
Why?
|
| Heart Ventricles | 1 | 2012 | 849 | 0.290 |
Why?
|
| Obesity | 3 | 2009 | 2891 | 0.290 |
Why?
|
| Biophysics | 1 | 2006 | 111 | 0.280 |
Why?
|
| Scattering, Radiation | 5 | 2010 | 316 | 0.270 |
Why?
|
| Thermodynamics | 4 | 2010 | 196 | 0.260 |
Why?
|
| Stroke | 1 | 2013 | 1155 | 0.250 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 453 | 0.250 |
Why?
|
| Kinetics | 6 | 2010 | 2041 | 0.240 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2017 | 445 | 0.240 |
Why?
|
| Diabetes Complications | 1 | 2006 | 310 | 0.230 |
Why?
|
| Antimalarials | 1 | 2023 | 55 | 0.230 |
Why?
|
| Malaria | 1 | 2023 | 93 | 0.220 |
Why?
|
| Models, Molecular | 2 | 2007 | 1740 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2015 | 305 | 0.190 |
Why?
|
| Nerve Block | 1 | 2022 | 176 | 0.190 |
Why?
|
| Cardioplegic Solutions | 1 | 2020 | 21 | 0.180 |
Why?
|
| Light | 4 | 2009 | 247 | 0.180 |
Why?
|
| Heart-Assist Devices | 1 | 2009 | 1173 | 0.180 |
Why?
|
| Quinolines | 1 | 2023 | 383 | 0.180 |
Why?
|
| Heart Arrest, Induced | 1 | 2020 | 87 | 0.180 |
Why?
|
| Propensity Score | 2 | 2020 | 755 | 0.160 |
Why?
|
| Phase Transition | 2 | 2010 | 17 | 0.160 |
Why?
|
| Ultrasonography, Interventional | 2 | 2022 | 433 | 0.150 |
Why?
|
| Humans | 26 | 2023 | 262243 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2016 | 1531 | 0.140 |
Why?
|
| Nausea | 1 | 2018 | 525 | 0.140 |
Why?
|
| Fatigue | 2 | 2022 | 1240 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 847 | 0.140 |
Why?
|
| Heart Failure | 1 | 2010 | 2523 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 351 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 802 | 0.130 |
Why?
|
| Atrial Appendage | 1 | 2015 | 55 | 0.130 |
Why?
|
| Male | 14 | 2020 | 123336 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 4945 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2018 | 562 | 0.120 |
Why?
|
| Retrospective Studies | 11 | 2022 | 38006 | 0.120 |
Why?
|
| Time Factors | 6 | 2017 | 12984 | 0.120 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 3482 | 0.120 |
Why?
|
| Cause of Death | 1 | 2017 | 757 | 0.120 |
Why?
|
| Intraoperative Period | 1 | 2013 | 247 | 0.110 |
Why?
|
| Algorithms | 3 | 2016 | 3888 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1958 | 0.110 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 54 | 0.110 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 121 | 0.110 |
Why?
|
| Cohort Studies | 4 | 2020 | 9284 | 0.110 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 148 | 0.100 |
Why?
|
| Perfusion | 1 | 2013 | 294 | 0.100 |
Why?
|
| Aged | 10 | 2020 | 70365 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2013 | 172 | 0.100 |
Why?
|
| Exome | 1 | 2016 | 1235 | 0.100 |
Why?
|
| Female | 13 | 2020 | 142292 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 687 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 257 | 0.090 |
Why?
|
| Treatment Outcome | 8 | 2017 | 33029 | 0.090 |
Why?
|
| Texas | 3 | 2017 | 6307 | 0.090 |
Why?
|
| Pain | 1 | 2018 | 1667 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2010 | 242 | 0.090 |
Why?
|
| Viscosity | 1 | 2009 | 47 | 0.090 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2009 | 125 | 0.080 |
Why?
|
| Temperature | 2 | 2010 | 508 | 0.080 |
Why?
|
| Protein Folding | 1 | 2010 | 282 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 83 | 0.080 |
Why?
|
| Muramidase | 1 | 2009 | 108 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2022 | 16217 | 0.080 |
Why?
|
| Reoperation | 2 | 2013 | 1405 | 0.080 |
Why?
|
| Cardiac Output, Low | 1 | 2009 | 81 | 0.080 |
Why?
|
| Elasticity | 1 | 2009 | 156 | 0.080 |
Why?
|
| Thrombectomy | 1 | 2009 | 158 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 1729 | 0.080 |
Why?
|
| Cytosol | 1 | 2009 | 237 | 0.080 |
Why?
|
| Hematoma | 1 | 2009 | 160 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 2267 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 549 | 0.080 |
Why?
|
| Quality of Life | 1 | 2022 | 4582 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 723 | 0.080 |
Why?
|
| Multienzyme Complexes | 2 | 2007 | 216 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2288 | 0.080 |
Why?
|
| Risk Factors | 6 | 2013 | 17622 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 655 | 0.070 |
Why?
|
| Middle Aged | 9 | 2015 | 86543 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2006 | 171 | 0.070 |
Why?
|
| Survival Rate | 2 | 2017 | 12239 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2013 | 6900 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2012 | 1868 | 0.060 |
Why?
|
| Phenotype | 1 | 2016 | 6258 | 0.060 |
Why?
|
| Length of Stay | 2 | 2009 | 1928 | 0.060 |
Why?
|
| Polymers | 1 | 2006 | 224 | 0.060 |
Why?
|
| Logistic Models | 4 | 2015 | 3450 | 0.060 |
Why?
|
| Adolescent | 3 | 2022 | 31244 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 303 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 4556 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2020 | 666 | 0.060 |
Why?
|
| Morbidity | 1 | 2006 | 402 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2006 | 477 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 14912 | 0.060 |
Why?
|
| Child | 3 | 2022 | 29066 | 0.060 |
Why?
|
| Hemin | 1 | 2023 | 24 | 0.060 |
Why?
|
| Inpatients | 1 | 2009 | 686 | 0.060 |
Why?
|
| Thrombosis | 1 | 2009 | 786 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 563 | 0.050 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 354 | 0.050 |
Why?
|
| Hospital Mortality | 3 | 2013 | 1308 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2012 | 2325 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 21735 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 1396 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 1330 | 0.040 |
Why?
|
| Erythrocytes | 2 | 2010 | 339 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 618 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 4323 | 0.040 |
Why?
|
| Ligation | 1 | 2015 | 193 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 1368 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 306 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 4786 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 2010 | 946 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 78173 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 138 | 0.020 |
Why?
|
| Heart Valves | 1 | 2010 | 66 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 1091 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 472 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2013 | 585 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 4354 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 2007 | 39 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2007 | 137 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 54 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 2782 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2007 | 294 | 0.020 |
Why?
|
| Mutation | 1 | 2006 | 15176 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 4903 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2010 | 453 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 12919 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2005 | 105 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 672 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 2007 | 336 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 5713 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2009 | 2213 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 29996 | 0.010 |
Why?
|